Literature DB >> 11895784

Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells.

Silvia Deaglio1, Mercedes Zubiaur, Armando Gregorini, Flavia Bottarel, Clara M Ausiello, Umberto Dianzani, Jaime Sancho, Fabio Malavasi.   

Abstract

CD38, a surface glycoprotein of unrestricted lineage, is an ectoenzyme (adenosine diphosphate [ADP] ribosyl cyclase/cyclic ADP-ribose hydrolase) that regulates cytoplasmic calcium. The molecule also performs as a receptor, modulating cell-cell interactions and delivering transmembrane signals, despite showing a structural ineptitude to the scope. CD38 ligation by agonistic monoclonal antibodies induced signals leading to activation of the lytic machinery of natural killer (NK) cells from adults; similar signals could not be reproduced in YT and NKL, 2 CD16(-) human NK-like lines. It was hypothesized that CD38 establishes a functional cooperation with professional signaling molecules of the NK cell surface. The present work answers the question about the molecule exploited by CD38 for signaling in NK cells, using as a model CD16(-) NK lines genetically corrected for CD16 expression. Our results indicate that a functional CD16 molecule is a necessary and sufficient requisite for CD38 to control an activation pathway, which includes calcium fluxes, tyrosine phosphorylation of ZAP70 and mitogen-activated protein kinase, secretion of interferon-gamma, and cytotoxic responses. Fluorescence resonance energy transfer and cocapping experiments also showed a surface proximity between CD38 and CD16. These results were confirmed by using the NKL cell line, in which CD16(+) and CD16(-) variants were obtained without genetic manipulation. Together, our findings show CD38 to be a unique receptor molecule that cannot signal by itself but whose receptor function is rescued by functional and physical associations with a professional signaling structure that varies according to lineage and environment. This molecule is CD16 in NK cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895784     DOI: 10.1182/blood.v99.7.2490

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.

Authors:  Elizabeth L McMichael; Nicholas B Courtney; Megan C Duggan; Robert Wesolowski; Dionisia Quiroga; Sri Vidya Kondadasula; Lakhvir S Atwal; Neela Bhave; Eric Luedke; Alena Cristina Jaime-Ramirez; Amanda R Campbell; Xiaokui Mo; John C Byrd; William E Carson Iii
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

2.  CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis.

Authors:  Héctor Romero-Ramírez; Monserrat Teresa Morales-Guadarrama; Rosana Pelayo; Rubén López-Santiago; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

3.  The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes.

Authors:  Nicola Lo Buono; Rossella Parrotta; Simona Morone; Paola Bovino; Giulia Nacci; Erika Ortolan; Alberto L Horenstein; Alona Inzhutova; Enza Ferrero; Ada Funaro
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

4.  Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

Authors:  Vivek Naranbhai; Salim S Abdool Karim; Marcus Altfeld; Natasha Samsunder; Raveshni Durgiah; Sengeziwe Sibeko; Quarraisha Abdool Karim; William H Carr
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

5.  Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo-Expanded Autologous NK Cells.

Authors:  Yufeng Wang; Yibo Zhang; Tiffany Hughes; Jianying Zhang; Michael A Caligiuri; Don M Benson; Jianhua Yu
Journal:  Clin Cancer Res       Date:  2018-04-17       Impact factor: 12.531

Review 6.  Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.

Authors:  Silvia Deaglio; Simon C Robson
Journal:  Adv Pharmacol       Date:  2011

7.  Daratumumab induces CD38 internalization and impairs myeloma cell adhesion.

Authors:  Jayeeta Ghose; Domenico Viola; Cesar Terrazas; Enrico Caserta; Estelle Troadec; Jihane Khalife; Emine Gulsen Gunes; James Sanchez; Tinisha McDonald; Guido Marcucci; Balveen Kaur; Michael Rosenzweig; Jonathan Keats; Steven Rosen; Amrita Krishnan; Abhay R Satoskar; Craig C Hofmeister; Flavia Pichiorri
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

8.  Differences amid bone marrow and cord blood hematopoietic stem/progenitor cell division kinetics.

Authors:  Cláudia Lobato da Silva; Raquel Gonçalves; Christopher D Porada; João L Ascensão; Esmail D Zanjani; Joaquim M S Cabral; Graça Almeida-Porada
Journal:  J Cell Physiol       Date:  2009-07       Impact factor: 6.384

9.  All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Immunobiology       Date:  2014-09-16       Impact factor: 3.144

10.  The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Shoshana Levy; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.